Filtered By:
Infectious Disease: SARS
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 80785 results found since Jan 2013.
Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
Reumatismo. 2023 Sep 18;75(3). doi: 10.4081/reumatismo.2023.1601.ABSTRACTWe read with interest the article by Camargo-Coronel et al. reporting on a systematic review of patients with idiopathic, inflammatory myopathy developing after anti-SARS-CoV-2 vaccinations.PMID:37721345 | DOI:10.4081/reumatismo.2023.1601
Source: Reumatismo - September 18, 2023 Category: Rheumatology Authors: J Finsterer A S MohanaSundaram F Scorza Source Type: research
Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
Reumatismo. 2023 Sep 18;75(3). doi: 10.4081/reumatismo.2023.1623.ABSTRACTWe thank Finsterer et al. for the attention paid to our publication; we recognize the validity of the points mentioned in their letter to the editor and will try to answer the observations made.PMID:37721344 | DOI:10.4081/reumatismo.2023.1623
Source: Reumatismo - September 18, 2023 Category: Rheumatology Authors: H Qui ñones-Moya A Camargo-Coronel M R Hern ández-Zavala Source Type: research
Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
Reumatismo. 2023 Sep 18;75(3). doi: 10.4081/reumatismo.2023.1601.ABSTRACTWe read with interest the article by Camargo-Coronel et al. reporting on a systematic review of patients with idiopathic, inflammatory myopathy developing after anti-SARS-CoV-2 vaccinations.PMID:37721345 | DOI:10.4081/reumatismo.2023.1601
Source: Reumatismo - September 18, 2023 Category: Rheumatology Authors: J Finsterer A S MohanaSundaram F Scorza Source Type: research
Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
Reumatismo. 2023 Sep 18;75(3). doi: 10.4081/reumatismo.2023.1623.ABSTRACTWe thank Finsterer et al. for the attention paid to our publication; we recognize the validity of the points mentioned in their letter to the editor and will try to answer the observations made.PMID:37721344 | DOI:10.4081/reumatismo.2023.1623
Source: Reumatismo - September 18, 2023 Category: Rheumatology Authors: H Qui ñones-Moya A Camargo-Coronel M R Hern ández-Zavala Source Type: research
Monitoring strategy of COVID-19 vaccination in dialysis patients based on a multiplex immunodot method: The CovidDial study
CONCLUSION: Three doses of mRNA-1273 vaccine induce a robust but time-limited immunologic response in dialysis patients. Lower anti-spike antibodies titers after initial vaccination are associated with a higher risk to subsequently contract SARS-CoV-2, even beyond 6 months.PMID:37718617 | DOI:10.1111/sdi.13175
Source: Seminars in Dialysis - September 18, 2023 Category: Urology & Nephrology Authors: Fr édéric Debelle Vo Thanh Phuong Nguyen Laurence Boitquin Miguel-Ange Guillen-Anaya Fabrice Gankam Anne-Emilie Decl èves CoviDial study group Source Type: research
CHEDDAR score versus YEARS algorithm for suspected pulmonary embolism in SARS-CoV-2-infected patients: A comparison of two strategies
Eur J Intern Med. 2023 Sep 16:S0953-6205(23)00328-X. doi: 10.1016/j.ejim.2023.09.008. Online ahead of print.NO ABSTRACTPMID:37722931 | DOI:10.1016/j.ejim.2023.09.008
Source: European Journal of Internal Medicine - September 18, 2023 Category: Internal Medicine Authors: Anabel Franco-Moreno Aida Izquierdo-Mart ínez Idoia Pagai-Valc árcel Juan Torres-Macho Cristina Luc ía de Ancos-Aracil CHEDDAR Research Group Source Type: research
High incidence of SARS-CoV-2 severe pneumonia in urban metropolitan areas: a suggestive pathogenetic hypothesis
Wien Klin Wochenschr. 2023 Sep 18. doi: 10.1007/s00508-023-02279-0. Online ahead of print.NO ABSTRACTPMID:37721587 | DOI:10.1007/s00508-023-02279-0
Source: Wiener Klinische Wochenschrift - September 18, 2023 Category: General Medicine Authors: Nicola Abrescia Adelaide Maddaloni Maurizio D'Abbraccio Mario De Marco Source Type: research
Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2)
CONCLUSION: Nirmatrelvir-ritonavir and molnupiravir probably improve outcomes for outpatients with mild to moderate COVID-19.PRIMARY FUNDING SOURCE: American College of Physicians. (PROSPERO: CRD42023406456).PMID:37722115 | DOI:10.7326/M23-1626
Source: Annals of Internal Medicine - September 18, 2023 Category: Internal Medicine Authors: Isolde Sommer Dominic Ledinger Kylie Thaler Andreea Dobrescu Emma Persad Martin Fangmeyer Irma Klerings Gerald Gartlehner Source Type: research
Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2)
Ann Intern Med. 2023 Sep 19. doi: 10.7326/M23-1636. Online ahead of print.ABSTRACTDESCRIPTION: Evidence for the use of outpatient treatments in adults with confirmed COVID-19 continues to evolve with new data. This is version 2 of the American College of Physicians (ACP) living, rapid practice points focusing on 22 outpatient treatments for COVID-19, specifically addressing the dominant SARS-CoV-2 Omicron variant.METHODS: The Population Health and Medical Science Committee (formerly the Scientific Medical Policy Committee) developed this version of the living, rapid practice points on the basis of a living, rapid review do...
Source: Annals of Internal Medicine - September 18, 2023 Category: Internal Medicine Authors: Amir Qaseem Jennifer Yost George M Abraham Rebecca Andrews Janet A Jokela Matthew C Miller Linda L Humphrey Population Health and Medical Science Committee of the American College of Physicians Source Type: research
Treatments for COVID-19
Annu Rev Med. 2023 Sep 18. doi: 10.1146/annurev-med-052422-020316. Online ahead of print.ABSTRACTThe treatment for COVID-19 has evolved rapidly since the start of the pandemic and now consists mainly of antiviral and immunomodulatory agents. Antivirals, such as remdesivir and nirmatrelvir-ritonavir, have proved to be most useful earlier in illness (e.g., as outpatient therapy) and for less severe disease. Immunomodulatory therapy, such as dexamethasone and interleukin-6 or Janus kinase inhibitors, are most useful in severe disease or critical illness. The role of anti-SARS-CoV-2 monoclonal antibodies has diminished because...
Source: Annual Review of Medicine - September 18, 2023 Category: General Medicine Authors: Hayden S Andrews Jonathan D Herman Rajesh T Gandhi Source Type: research
Monitoring strategy of COVID-19 vaccination in dialysis patients based on a multiplex immunodot method: The CovidDial study
CONCLUSION: Three doses of mRNA-1273 vaccine induce a robust but time-limited immunologic response in dialysis patients. Lower anti-spike antibodies titers after initial vaccination are associated with a higher risk to subsequently contract SARS-CoV-2, even beyond 6 months.PMID:37718617 | DOI:10.1111/sdi.13175
Source: Seminars in Dialysis - September 18, 2023 Category: Urology & Nephrology Authors: Fr édéric Debelle Vo Thanh Phuong Nguyen Laurence Boitquin Miguel-Ange Guillen-Anaya Fabrice Gankam Anne-Emilie Decl èves CoviDial study group Source Type: research
Treatments for COVID-19
Annu Rev Med. 2023 Sep 18. doi: 10.1146/annurev-med-052422-020316. Online ahead of print.ABSTRACTThe treatment for COVID-19 has evolved rapidly since the start of the pandemic and now consists mainly of antiviral and immunomodulatory agents. Antivirals, such as remdesivir and nirmatrelvir-ritonavir, have proved to be most useful earlier in illness (e.g., as outpatient therapy) and for less severe disease. Immunomodulatory therapy, such as dexamethasone and interleukin-6 or Janus kinase inhibitors, are most useful in severe disease or critical illness. The role of anti-SARS-CoV-2 monoclonal antibodies has diminished because...
Source: Annual Review of Medicine - September 18, 2023 Category: General Medicine Authors: Hayden S Andrews Jonathan D Herman Rajesh T Gandhi Source Type: research
CHEDDAR score versus YEARS algorithm for suspected pulmonary embolism in SARS-CoV-2-infected patients: A comparison of two strategies
Eur J Intern Med. 2023 Sep 16:S0953-6205(23)00328-X. doi: 10.1016/j.ejim.2023.09.008. Online ahead of print.NO ABSTRACTPMID:37722931 | DOI:10.1016/j.ejim.2023.09.008
Source: European Journal of Internal Medicine - September 18, 2023 Category: Internal Medicine Authors: Anabel Franco-Moreno Aida Izquierdo-Mart ínez Idoia Pagai-Valc árcel Juan Torres-Macho Cristina Luc ía de Ancos-Aracil CHEDDAR Research Group Source Type: research
Case report on meningoenceplapathy in an Indian patient post CoViD vaccination
Bioinformation. 2023 Jan 31;19(1):117-119. doi: 10.6026/97320630019117. eCollection 2023.ABSTRACTThe SARS-COV-2 infection-related severe illness is prevented by vaccinations. Therefore, it is relevant to report a case of post vaccine meningoencephalitis in a 30 year old male Indian patient, who presented with weakness in all the extremities, episodes of loose stool, fever, vomiting, tachypnea and loss of consciousness immediately following the 2nd dose of the COVID vaccination (COVAXIN).PMID:37720286 | PMC:PMC10504505 | DOI:10.6026/97320630019117
Source: Bioinformation - September 18, 2023 Category: Bioinformatics Authors: Raj Kamal Choudhry Amrendra Kumar Singh Kumar Sourav Anjum Pervez Abilesh Kumar Subham Kumar Source Type: research
High incidence of SARS-CoV-2 severe pneumonia in urban metropolitan areas: a suggestive pathogenetic hypothesis
Wien Klin Wochenschr. 2023 Sep 18. doi: 10.1007/s00508-023-02279-0. Online ahead of print.NO ABSTRACTPMID:37721587 | DOI:10.1007/s00508-023-02279-0
Source: Wiener Klinische Wochenschrift - September 18, 2023 Category: General Medicine Authors: Nicola Abrescia Adelaide Maddaloni Maurizio D'Abbraccio Mario De Marco Source Type: research
